ABBV: Message Board for AbbVie Inc. - InvestorVillage


AbbVie Inc.

  ABBV website

ABBV   /  Message Board

 
BOARD

GROUPS
 





 
Loading...
 
 
--




Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
608 Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie GN jerrykrause 0 1/11/2022 7:08:55 PM
607 AbbVie confirms prior Rinvoq/Skyrizi revenue guidance for 2025; sees lower than expected Rinvoq U.S. sales due to label updates GN jerrykrause 1 1/11/2022 1:06:43 PM
606 AbbVie’s Next Generation Drugs Are Poised to Help Mitigate Upcoming Humira Biosimilar Pressures GN jerrykrause 2 1/6/2022 1:00:14 PM
605 AbbVie ends enrollment in Idera collab as the biotech winds down its own colorectal cancer trial GN jerrykrause 0 12/16/2021 1:30:06 PM
604 AbbVie on Track for Record High Close GN jerrykrause 1 12/14/2021 12:27:01 PM
603 SpringWorks Therapeutics Announces Clinical Collaboration with AbbVie to Evaluate Nirogacestat in Combination with ABBV-383 in Patients with Relapsed or Refractory Multiple Myeloma GN jerrykrause 0 12/11/2021 1:32:34 PM
602 AbbVie's blockbuster hopeful Rinvoq notched a win in a tricky-to-treat group of Crohn's disease patients, potentially adding another arrow to the company's post-Humira quiver. The JAK inhibitor helped a "significantly" greater proportion of patients achi GN jerrykrause 0 12/7/2021 6:10:16 PM
601 AbbVie's Rinvoq notches Crohn's disease win amid classwide JAK safety concerns GN jerrykrause 0 12/7/2021 6:08:38 PM
600 AbbVie's Parkinson's pump hits goal in phase 3, setting stage for approval filings GN jerrykrause 1 11/2/2021 7:54:18 PM
599 AbbVie plans product launches in India from global portfolio GN jerrykrause 1 10/28/2021 6:43:29 PM
Previous 592 Messages Top of Message List Post Message Go to Msg #  


Financial Market Data provided by
.
Loading...